Advocacy Partner: Global Liver Institute
About Global Liver Institute
Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease.
Contact: Christine Maalouf – Communications Director
Phone: (800) 845-5910
Email: [email protected]
Resources
Liver Health Basics
This booklet provides a foundation for understanding of liver health, providing the function of the liver, common symptoms of liver disease, overview of the major types, and an outline of liver-healthy habits.
Download your free booklet here.
When Treatment Is No Longer Available FAQ Sheet
Facing a medication change can be confusing and stressful, but you don’t have to navigate it alone. Our “When Treatment is No Longer Available” FAQ sheet is here to guide you through the process, answering the questions patients ask most: Why was this medication withdrawn? What should I do next? Who can I turn to for support?
Developed with input from Dr. Julio Guitterez, an expert transplant hepatologist at Scripps Health, expertise from primary biliary cholangitis (PBC) patient advocacy organizations, and with the support of Intercept Pharmaceuticals, this free resource uses PBC as a case study to provide real-life examples. The information shared also applies broadly to many situations where rare disease medications are discontinued.
Download your free FAQ Sheet here.
Beyond the Biopsy
Join Global Liver Institute and Liver Coalition of San Diego for an important discussion on early detection and diagnosis of MASH. Learn how early risk-stratification, better referral pathways, and emerging treatment options, such as FDA-approved therapies for F2/F3 fibrosis, are improving outcomes and helping patients avoid progression to cirrhosis. This educational forum highlights practical strategies for clinicians, advocates, and community leaders working to advance liver health.
Upcoming events
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
This article was provided by our partner, Global Liver Institute. It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and do not necessarily reflect the views of Bionews or Liver Disease News. If you had…
This article was provided by our partner, Global Liver Institute. It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and do not necessarily reflect the views of Bionews or Liver Disease News.